News

Firefighters were called to the Pine Street apartment building around 1:30 a.m. and found flames shooting from the second and ...
Dan Buettner, a Florida-based author, explorer and longevity expert, says that in the “blue zones,” where a greater number of ...
A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...
The U.S. Supreme Court’s recent decision in Medical Marijuana v. Horn expands the reach of the Racketeer Influenced and Corrupt Organizations Act (RICO), clarifying that injuries to business or ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
The Supreme Court’s decision clarifies the civil damages provision of the Racketeer Influenced and Corrupt Organizations (RICO) Act. On April ...
The Sixth Circuit rejected US Framing's claim that a general contractor committed insurance fraud in a multimillion-dollar subguard claim ...
Originally approved by the FDA in 1998, Amgen’s Enbrel is still sailing along without facing biosimilar competition in the ...
Four years ago, a triple murder took place in Chickasha. The victims' families told KOCO that their final chance at justice was taken from them today with the cases against Gov. Kevin Stitt's Office ...
Sandoz is suing Amgen over alleged patent abuse delaying the US launch of a biosimilar to the autoimmune drug Enbrel.
Opinion: Sullivan & Cromwell attorneys Thomas White and Andrew DeFilippis say the risk of False Claims Act violations will go ...